Speaker illustration

Professor Hubert Seggewiss

Comprehensive Heart Failure Center (CHFC), Wurzburg (Germany)

Member of:

European Society of Cardiology

Medical study in Cologne and Muenster, training in Minden and Bad Oeynhausen (Heart Center NRW) 1987 Doctor of Internal Medicine, 1988 Cardiology, 1995 Internal Intensive Care Medicine 1994 Postdoctural Thesis: „PTCA in Patients with Multivessel Disease - Clinical follow-Up with Respect to Degree of Revascularization" Qualification as University Lecturer (Venia legendi in Internal Medicine) at the Ruhr-University Bochum 1999 Prof. of Internal Medicine/Cardiology, University Bochum, 2016 Prof. of Internal Medicine/Cardiology, University Würzburg 2000 – 2017 Director Medizinische Klinik I, Leopoldina-Krankenhaus, Schweinfurt Since 4/2020 CHFC/University Clinic Würzburg Main interest and experience in clinical and interventional cardiology with special focus on HCM with large experience in alcohol septal ablation in HOCM since 1996

Novel therapeutic targets in hypertrophic cardiomyopathy

Event: ESC Congress 2019

Topic: Hypertrophic Cardiomyopathy

Session type: Advances in Science


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb